000 | 01715 a2200469 4500 | ||
---|---|---|---|
005 | 20250516204334.0 | ||
264 | 0 | _c20140718 | |
008 | 201407s 0 0 eng d | ||
022 | _a1530-0307 | ||
024 | 7 |
_a10.1038/labinvest.2014.51 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aZhong, Jianyong | |
245 | 0 | 0 |
_aVitronectin-binding PAI-1 protects against the development of cardiac fibrosis through interaction with fibroblasts. _h[electronic resource] |
260 |
_bLaboratory investigation; a journal of technical methods and pathology _cJun 2014 |
||
300 |
_a633-44 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 | _aAnalysis of Variance |
650 | 0 | 4 | _aAngiotensin II |
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aApoptosis _xdrug effects |
650 | 0 | 4 | _aCell Movement |
650 | 0 | 4 |
_aCell Proliferation _xdrug effects |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 |
_aFibrinogen _xmetabolism |
650 | 0 | 4 |
_aFibrinolysin _xmetabolism |
650 | 0 | 4 |
_aFibroblasts _xdrug effects |
650 | 0 | 4 |
_aFibrosis _xmetabolism |
650 | 0 | 4 | _aHeart Ventricles |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aMice |
650 | 0 | 4 | _aMice, Inbred C57BL |
650 | 0 | 4 |
_aMyocardium _xpathology |
650 | 0 | 4 |
_aPlasminogen Activator Inhibitor 1 _xchemistry |
650 | 0 | 4 |
_aVitronectin _xmetabolism |
700 | 1 | _aYang, Hai-Chun | |
700 | 1 | _aKon, Valentina | |
700 | 1 | _aFogo, Agnes B | |
700 | 1 | _aLawrence, Daniel A | |
700 | 1 | _aMa, Ji | |
773 | 0 |
_tLaboratory investigation; a journal of technical methods and pathology _gvol. 94 _gno. 6 _gp. 633-44 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1038/labinvest.2014.51 _zAvailable from publisher's website |
999 |
_c23694005 _d23694005 |